Kenvue Inc. (KVUE)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Key Insights
Share Price
$22.74Market Cap
$43.55 BillionTotal Outstanding Shares
1.92 Billion SharesTotal Employees
22,000Dividend
$0.205 Per Share QuarterlyIPO Date
May 4, 2023SIC Description
Perfumes, Cosmetics & Other Toilet PreparationsHomepage
https://www.kenvue.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $-36.00 Million |
| Net Cash Flow From Investing Activities, Continuing | $-607.00 Million |
| Net Cash Flow From Financing Activities | $-1.93 Billion |
| Net Cash Flow | $-225.00 Million |
| Net Cash Flow, Continuing | $-181.00 Million |
| Net Cash Flow From Investing Activities | $-607.00 Million |
| Net Cash Flow From Operating Activities | $2.35 Billion |
| Net Cash Flow From Operating Activities, Continuing | $2.35 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-1.93 Billion |
Income Statement
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Revenues | $15.47 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Gross Profit | $8.90 Billion |
| Operating Expenses | $7.25 Billion |
| Selling, General, and Administrative Expenses | $6.33 Billion |
| Income Tax Expense/Benefit | $315.00 Million |
| Income/Loss From Continuing Operations Before Tax | $1.43 Billion |
| Research and Development | $416.00 Million |
| Diluted Average Shares | $5.78 Billion |
| Basic Average Shares | $5.77 Billion |
| Costs And Expenses | $14.04 Billion |
| Net Income/Loss | $1.12 Billion |
| Operating Income/Loss | $1.77 Billion |
| Nonoperating Income/Loss | $-57.00 Million |
| Income/Loss From Continuing Operations After Tax | $1.12 Billion |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | $0.58 |
| Net Income/Loss Attributable To Parent | $1.12 Billion |
| Benefits Costs and Expenses | $14.04 Billion |
| Income Tax Expense/Benefit, Deferred | $-335.00 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $1.12 Billion |
| Basic Earnings Per Share | $0.58 |
| Cost Of Revenue | $6.58 Billion |
Balance Sheet
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Assets | $26.44 Billion |
| Inventory | $1.85 Billion |
| Liabilities | $16.27 Billion |
| Current Assets | $5.88 Billion |
| Equity Attributable To Parent | $10.18 Billion |
| Current Liabilities | $5.94 Billion |
| Liabilities And Equity | $26.44 Billion |
| Accounts Payable | $2.44 Billion |
| Noncurrent Assets | $20.56 Billion |
| Other Non-current Assets | $9.80 Billion |
| Intangible Assets | $8.76 Billion |
| Wages | $253.00 Million |
| Other Current Assets | $4.03 Billion |
| Fixed Assets | $2.00 Billion |
| Other Current Liabilities | $3.25 Billion |
| Noncurrent Liabilities | $10.33 Billion |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity | $10.18 Billion |
Historical Dividends
Current dividend: $0.205 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Oct 17, 2024 | Nov 27, 2024 | Nov 13, 2024 | $0.205 | Quarterly |
| Jul 25, 2024 | Aug 28, 2024 | Aug 14, 2024 | $0.205 | Quarterly |
| Apr 25, 2024 | May 22, 2024 | May 8, 2024 | $0.2 | Quarterly |
| Jan 25, 2024 | Feb 28, 2024 | Feb 14, 2024 | $0.2 | Quarterly |
| Oct 26, 2023 | Nov 22, 2023 | Nov 8, 2023 | $0.2 | Quarterly |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ2024 Financhle. All Rights Reserved.